GR-159897

GR-159897 is a chemical compound that acts as a selective antagonist for the neurokinin 1 receptor (NK1 receptor). It is primarily used in scientific research to study the role of NK1 receptors in various physiological and pathological processes.
Mechanism of Action[edit]
GR-159897 functions by binding to the NK1 receptor, thereby inhibiting the action of its natural ligand, substance P. Substance P is a neuropeptide involved in the transmission of pain and other sensory signals. By blocking the NK1 receptor, GR-159897 can modulate the effects of substance P, making it a valuable tool in the study of pain mechanisms and other conditions where substance P is implicated.
Applications in Research[edit]
GR-159897 is used extensively in preclinical research to explore the potential therapeutic benefits of NK1 receptor antagonism. Some of the key areas of research include:
- Pain Management: By blocking the action of substance P, GR-159897 is used to investigate new pain relief strategies, particularly in chronic pain conditions.
- Psychiatric Disorders: NK1 receptor antagonists like GR-159897 are studied for their potential in treating depression and anxiety disorders.
- Inflammatory Diseases: The role of substance P in inflammation makes GR-159897 a useful compound in studying inflammatory pathways and potential treatments.
Chemical Properties[edit]
GR-159897 is characterized by its specific chemical structure, which allows it to selectively bind to the NK1 receptor. The compound's structure is depicted in the image to the right, highlighting its molecular configuration.
Safety and Handling[edit]
As with many research chemicals, GR-159897 should be handled with care in a laboratory setting. Appropriate safety measures, including the use of personal protective equipment (PPE) and adherence to safety protocols, are essential to ensure safe handling and experimentation.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian